This comprehensive study evaluates the statutory requirements, historical development, and practical application of United States federal and Indiana state Research and Development (R&D) tax credits specifically within the industrial ecosystem of Evansville, Indiana. Through detailed analysis of administrative guidance, case law, and five unique regional industry case studies, this document outlines how Evansville’s legacy of manufacturing innovation continues to align with stringent modern tax incentive frameworks.

Part I: The United States Federal R&D Tax Credit Legal Framework

The federal Credit for Increasing Research Activities, commonly referred to as the R&D tax credit, was originally enacted as part of the Economic Recovery Tax Act of 1981 to stimulate capital investment, incentivize domestic technological innovation, and ensure the long-term economic competitiveness of the United States on the global stage. Codified under Title 26 of the United States Code, specifically Internal Revenue Code (IRC) Section 41, the provision offers a highly lucrative, dollar-for-dollar reduction in a taxpayer’s federal income tax liability, directly offsetting the immense costs associated with pioneering new technologies. The core philosophical underpinning of the federal credit is to reward enterprises that willingly assume financial risk by investing resources into the resolution of complex technical uncertainties through empirical scientific experimentation.

1.1 The Section 41 Conjunctive Four-Part Test

For any specific industrial activity to be legally deemed “qualified research” under federal law, it must satisfy a rigorous, conjunctive four-part test as explicitly outlined in IRC § 41(d). A failure to satisfy any single prong of this test disqualifies the associated expenditures from credit eligibility entirely. The Internal Revenue Service (IRS) mandates that these statutory tests be applied separately and individually to each “business component”—which is legally defined as a product, process, computer software, technique, formula, or invention that is held for sale, lease, or license, or used by the taxpayer in their own trade or business.

The Section 174 Test (Permitted Purpose) The foundational prong requires that the expenditures connected to the research activity must be eligible for treatment as specified research or experimental expenditures under IRC § 174. Section 174 governs the accounting and amortization of research costs incurred in connection with the taxpayer’s active trade or business. To meet the permitted purpose requirement, the fundamental objective of the research activities must be intended to discover information that will develop a new or improved business component, focusing specifically on enhancing functionality, performance, reliability, or quality. Aesthetics, cosmetic alterations, seasonal design variations, or general market adaptations are explicitly excluded from this statutory definition. The ultimate commercial success of the business component is irrelevant; the test focuses solely on the intent to achieve a functional improvement.

The Technological in Nature Test The research undertaken must be fundamentally intended to discover information that is inherently technological in nature. To satisfy this stringent requirement, the process of experimentation must fundamentally rely upon the established principles of the hard sciences: physical sciences, biological sciences, computer science, or engineering. Activities based on the social sciences, arts, or humanities—such as market research, psychological consumer studies, management efficiency surveys, or economic forecasting—are statutorily precluded from consideration. The IRS scrutinizes this element to ensure that the credit subsidizes actual scientific and engineering labor rather than administrative or commercial optimization.

The Elimination of Uncertainty Test At the outset of the research and development initiative, the taxpayer must encounter definitive technical uncertainty regarding the development or improvement of the business component. The IRS defines technical uncertainty as an objective state wherein the information available to the taxpayer does not clearly establish the capability of developing the business component, the optimal method or methodology of its development, or the appropriate final design of the product or process. The primary objective of the research endeavor must be to discover specific technological information that actively eliminates these uncertainties through direct inquiry. If a competent professional in the field could easily deduce the solution using standard industry knowledge without empirical testing, no qualifying uncertainty exists.

The Process of Experimentation Test Substantially all of the research activities—defined administratively by the IRS as 80 percent or more of the measured effort—must constitute elements of a formalized process of experimentation for a qualified purpose. This involves a systematic, methodical approach designed to evaluate one or more alternatives to achieve the desired result. Acceptable methods include physical prototype testing, systematic trial and error, sophisticated computational modeling, and computer simulation (such as Finite Element Analysis or Computational Fluid Dynamics). The process must inherently incorporate the formulation of a scientific hypothesis, the execution of a test or series of tests, the rigorous analysis of the resultant data, and the subsequent refinement of the hypothesis or design based on empirical findings.

1.2 Qualified Research Expenses (QREs)

If an industrial project or developmental initiative successfully satisfies the conjunctive four-part test, the taxpayer may claim specific financial expenditures associated directly with the activity. Under IRC § 41(b), Qualified Research Expenses (QREs) are strictly categorized into three primary statutory buckets:

First, the law allows the inclusion of taxable wages. This includes W-2 taxable wages paid to employees who are directly engaged in the performance of qualified research, those immediately supervising the qualified research, or those directly supporting the qualified research activities. Direct support might encompass a machinist fabricating an experimental prototype or a laboratory technician cleaning specialized beakers used in a chemical synthesis trial. Administrative, human resources, and general management wages are strictly excluded.

Second, taxpayers may capture the cost of research supplies. A qualified supply is defined as tangible property used or consumed in the active conduct of qualified research. This critical category explicitly excludes land, improvements to land, and depreciable property (such as the capital purchase of a new manufacturing machine or a permanent laboratory building). However, raw materials, testing chemicals, experimental resin batches, prototype components, and electricity directly consumed during specialized testing routinely qualify under this category, making it highly lucrative for heavy industrial manufacturers.

Third, the framework permits the inclusion of Contract Research Expenses. These are payments made to third-party contractors, engineering firms, or independent testing laboratories performing qualified research on behalf of the taxpayer. By statutory default, these expenses are subject to a rigid 65 percent limitation, meaning only 65 percent of the invoiced amount is eligible for the final credit computation, acknowledging that contractor invoices include overhead and profit margins. Specific statutory exceptions exist, however, for payments made to qualified research consortiums—organizations exempt from tax under IRC § 501(c)(3) or 501(c)(6) and organized primarily to conduct scientific research—which allow for a higher 75 percent expense inclusion.

1.3 Federal Exclusions and the IRS Audit Posture

IRC § 41(d)(4) identifies specific categories of activities that are statutorily excluded from the definition of qualified research, regardless of whether they appear technical in nature. These exclusions act as a definitive boundary for the credit’s applicability. Excluded activities encompass research conducted after commercial production of the business component has commenced (troubleshooting or routine quality control), adaptation of an existing business component to a particular customer’s requirement without introducing new functionality, duplication or reverse engineering of an existing product, and research conducted entirely outside the geographical boundaries of the United States.

Furthermore, the code excludes any research that is funded by another entity, such as a grant or a specific customer contract. Research is considered funded if the taxpayer does not retain substantial rights to the intellectual property or the commercial results of the research, or if the taxpayer’s payment for the research is not explicitly contingent upon the technological success of the endeavor. If a manufacturer is guaranteed payment regardless of whether their developmental prototype functions correctly, they bear no financial risk, and the IRS will disallow the associated expenses.

The IRS evaluates research credit claims with an exceptionally high degree of scrutiny, utilizing specialized Audit Techniques Guides (ATGs) to provide revenue agents with industry-specific frameworks for assessing compliance risk. These guides detail common industry practices, accounting methods, and standard operating procedures to help auditors evaluate complex engineering and scientific claims. For example, the ATG dedicated to the pharmaceutical industry provides a granular risk analysis of a typical drug development pipeline. It designates fundamental discovery, pre-clinical biology, and manufacturing scale-up activities as “low risk” for audit challenges, meaning they almost always qualify. Conversely, post-approval Phase IV clinical trials, market access studies, and real-world evidence gathering are deemed “high risk,” as they often cross the line into post-commercialization marketing rather than hard science.

Part II: The Indiana State R&D Tax Credit Legal Framework

Operating in parallel with the federal incentive, the State of Indiana offers a highly robust Research Expense Credit, codified under Indiana Code (IC) 6-3.1-4. The Indiana legislature carefully designed this credit to harmonize largely with the federal IRC § 41 definitions, deliberately utilizing the exact same four-part test and Qualified Research Expense (QRE) definitions. However, Indiana imposes a strict geographic nexus requirement to ensure that the economic benefits of the subsidized research—job creation, capital investment, and intellectual property development—remain firmly within the state’s sovereign borders.

2.1 The Stringent Indiana Geographic Nexus Requirement

Under IC 6-3.1-4-1, an “Indiana qualified research expense” is defined narrowly as a qualified research expense (as defined by IRC § 41(b)) that is incurred exclusively for research physically conducted in Indiana. The Indiana Department of Revenue (DOR) enforces this geographical requirement with intense rigor. When evaluating claims during an audit, the DOR meticulously considers the physical place where the services are performed, the legal residence or business location of the personnel performing the services, and the precise physical location where research supplies are consumed or destroyed during testing. Taxpayers operating multi-state enterprises must implement rigorous apportionment and allocation methodologies to strictly isolate Indiana-based activities from out-of-state operations. A federal QRE is not automatically an Indiana QRE; if a design is conceptualized in Evansville but tested at a subsidiary facility in Kentucky, the testing expenses fail the Indiana nexus requirement.

2.2 Indiana Credit Calculation Methodologies

Indiana offers multiple statutory mechanisms for calculating the research expense credit, providing tiered benefits based on the volume of historical and current research expenditures, thereby accommodating both legacy manufacturers and rapid-growth technology startups.

The Standard Incremental Method For Indiana qualified research expenses incurred after December 31, 2007, the standard calculation determines the credit based on the excess of current-year Indiana QREs over a historically established base amount. The calculation operates on a highly lucrative two-tiered percentage system designed to aggressively reward high-volume research:

• Tier 1: The taxpayer receives a 15 percent credit on the first $1 million of Indiana QREs that exceed the calculated base amount.
• Tier 2: A 10 percent credit is applied to any excess of Indiana QREs over the base amount that exceeds the initial $1 million threshold.

The Alternative Simplified Credit (ASC) Equivalent Taxpayers may elect an alternative calculation method if they lack sufficient historical documentation to establish a standard base amount from the 1980s, or if their historical gross receipts have fluctuated wildly. At the taxpayer’s election, the amount of the research expense tax credit is equal to 10 percent of the portion of the current year’s Indiana QREs that exceeds 50 percent of the taxpayer’s average Indiana QREs for the three immediately preceding taxable years. Furthermore, if the taxpayer is a newly established entity or did not possess any Indiana QREs in any one of the three preceding years, the credit is calculated as a flat 5 percent of the current year’s Indiana QREs, ensuring that startups can immediately benefit.

The Targeted Aerospace Industry Credit Recognizing the unique capital demands of the defense sector, Indiana provides a highly targeted incentive for advanced aerospace manufacturing. Under IC 6-3.1-4-2.5, certified aerospace advanced manufacturers—defined generally as US Department of Defense contractors maintaining significant manufacturing facilities in Indiana with at least 3,000 full-time employees earning substantially above the hourly minimum wage—may qualify for a specific alternative credit percentage. The Indiana Economic Development Corporation (IEDC) is authorized to determine this exact percentage, up to a statutory maximum of 10 percent, applied to the excess of current Indiana QREs over 50 percent of the prior three-year average.

2.3 Carryforward Provisions and Strict Utilization Rules

The mechanisms for credit utilization highlight a significant divergence between federal and state law. Unlike the federal R&D tax credit, which generally allows for a one-year carryback and a 20-year carryforward of unused credits, the Indiana research credit is entirely non-refundable and explicitly does not permit carrybacks to prior tax years. However, unused credits generated in the current year may be carried forward for a period of up to 10 consecutive taxable years to offset future adjusted gross income tax liabilities.

Indiana law imposes a strict, counter-intuitive ordering rule for the utilization of these credits. IC 6-3.1-4-3(b) dictates that a current-year credit must be used to offset that specific year’s tax liability before any accumulated carryforward credits from previous years can be applied. For example, if a taxpayer possesses a credit carryforward from 2018 and generates a new credit in 2024, the 2024 credit must be applied to the 2024 liability first. This prevents taxpayers from indefinitely rolling forward new credits while burning off expiring older ones. Furthermore, in the context of combined corporate group filings, the research expense credit carryforward must first be utilized by the specific earning member up to the extent of their individual tax liability before the excess can be shared with other subsidiary members of the combined group.

2.4 The Vital R&D Sales and Use Tax Exemption

Operating in powerful tandem with the income tax credit is the Indiana Sales and Use Tax Exemption for R&D equipment, codified at IC 6-2.5-5-40. This statutory provision offers a 100 percent sales tax exemption on the purchase of depreciable tangible personal property that is used directly in qualified research and development activities within the state.

This exemption acts as a critical financial offset for heavy industrial manufacturers who require expensive, specialized capital equipment—such as electron microscopes, pilot-scale chemical reactors, or advanced CNC milling machines—to conduct their process engineering and testing. Taxpayers claim this exemption directly at the point of sale by completing and presenting Form ST-105 (Indiana Sales and Use Tax Exemption Certificate) to the vendor. Alternatively, if the tax was mistakenly paid at the register, the taxpayer may file a timely claim for a retroactive refund of the sales tax paid on that specific retail transaction. To survive a DOR audit on this exemption, the purchaser must maintain records highly adequate to substantiate the purchase price and explicitly prove the equipment’s direct utilization in a qualifying research project.

Part III: Indiana Department of Revenue Administrative Guidance and Judicial Precedent

The practical application of the Indiana R&D tax credit is heavily dictated by the aggressive administrative posture of the Indiana Department of Revenue (DOR) and the binding rulings of the Indiana Tax Court. Recent administrative decisions demonstrate an increasingly stringent, unforgiving environment regarding evidentiary standards and documentation requirements.

3.1 The Strict Evidentiary Standard: Rejection of the Cohan Rule

The DOR has issued multiple critical Letters of Findings (e.g., LOF 02-20190975 and LOF 02-20191105) explicitly disallowing substantial research expense credits based entirely on insufficient documentation. In these rulings, the Department acknowledged that the evidence generally pointed to the performance of qualifying R&D activities, yet nonetheless revoked the credits because the documentation failed to meet the taxpayers’ legal burden of establishing exact cost allocations.

While federal courts—most notably the Fifth Circuit Court of Appeals in United States v. McFerrin—and IRS examination guidelines sometimes permit the use of oral testimony and after-the-fact mathematical estimations (an application of the judicial Cohan rule) to substantiate R&D wage claims, Indiana unequivocally rejects this methodology. The DOR officially maintains that “interviewing employees to reconstruct the activities believed to qualify (or not qualify) is insufficient in determining what employees did and whether such expenses qualify for the research credit”. Furthermore, the DOR stated in LOF 04-20210138 that reliance on employee interviews, post-project estimates, and statistical sampling “did not clearly establish it was entitled to the credits”.

Consequently, taxpayers claiming the Indiana credit must maintain robust, highly granular, contemporaneous documentation. This evidence must be generated precisely at the time the research was actively being conducted and includes laboratory notebooks, time-tracking software logs, daily engineering schematics, and prototype iteration reports. Random and unsupported allocations of time are summarily rejected; allocation percentages applied to Indiana-incurred expenses are accepted only when backed by substantial empirical evidence.

3.2 Statutory Compliance and Inter-Agency Reporting Directives

Legislative updates to IC 6-3.1-4, specifically following the passage of House Enrolled Act (HEA) 1001, require enhanced transparency and reporting parity between federal and state filings. Taxpayers who claim an Indiana qualified research expense credit for a taxable year are now statutorily mandated to formally report to the DOR whether they have determined and claimed a corresponding credit for those same expenses for federal purposes under IRC § 41(a)(1) or (c)(4).

If a taxpayer aggressively claims the Indiana credit for qualified research expenses but curiously does not claim an Indiana credit for those same expenses for federal tax purposes, the taxpayer must explicitly disclose to the DOR the precise reasons for this discrepancy. This disclosure must be made in the exact manner specified by the agency, acting as a procedural tripwire designed to trigger immediate audit scrutiny on anomalous, state-only claims. Any subsequent adjustments made to the federal credit by the IRS are considered a binding modification for state purposes under IC 6-3-4-6, allowing the state to instantly claw back previously awarded state credits.

3.3 Judicial Interpretation: The Complexities of the Funded Research Exclusion

Indiana Tax Court jurisprudence heavily influences the interpretation of federal statutory exclusions incorporated into state law, particularly the highly litigated “funded research” exclusion. Under this rule, research is disqualified if the taxpayer lacks substantial rights to the results or if the payment is not contingent on the success of the research.

In a notable recent dispute handled by the Tax Court, the IRS (and by extension, state authorities auditing equivalent provisions) attempted to disallow a manufacturing taxpayer’s credits by arguing that the specific contractual warranty provisions within their customer agreements completely overrode standard buyer remedies. The authorities argued that because the warranty limited liability, the taxpayer was not genuinely economically at risk, thus rendering the research legally “funded” by the customer.

The Tax Court strongly disagreed, finding that the scope and effect of the boilerplate warranty provisions did not foreclose other legal remedies in the event of a total project breach. Crucially, the court stated that if the research totally failed, Indiana state commercial law provided a fundamental remedy inclusive of full refunds of all payments made by the buyer. Because Indiana state law protected the buyer’s right to a refund in the event of failure, the payments for the research remained entirely contingent upon the technological success of the research. Therefore, the research was not funded, the taxpayer retained the financial risk, and the millions in research expenses were deemed fully eligible for the credit. This ruling highlights the profound intersection of state contract law and federal tax incentives.

Part IV: Evansville, Indiana – An Economic and Industrial Retrospective

Evansville, situated in Vanderburgh County along a deep, navigable meander of the Ohio River, anchors a massive regional economic hub in Southwestern Indiana affectionately known as the “Crescent Valley” or “River City”. The city possesses a rich, incredibly dynamic history of heavy manufacturing that provides the ideal geographical and cultural ecosystem for intensive research and development activities. Understanding why Evansville developed its specific industrial profile is critical to understanding how its current companies qualify for massive R&D tax incentives.

4.1 Historical Economic Evolution: From Timber to the Arsenal of Democracy

During the late 19th and early 20th centuries, Evansville aggressively leveraged its strategic Ohio River access and the vast surrounding hardwood forests to become a global leader in lumber processing and furniture production. By 1910, Evansville was home to the largest furniture company in the world, the Globe-Bosse-World Furniture Company, establishing a regional culture of mass-production line efficiency. Simultaneously, heavy metalworking took root; the Orr Iron Company, starting as a small blacksmith shop, rapidly expanded into a 75,000-square-foot warehouse operation serving the entire Midwest.

The industrial base evolved radically with the advent of World War II. Evansville swiftly transitioned its commercial manufacturing capacity into a vital node of the “Arsenal of Democracy,” pivoting to heavy metal fabrication and munitions. The city hosted two major companies that built Landing Ship, Tanks (LSTs) and fighter aircraft for the military effort. This monumental wartime production effort employed tens of thousands of people, driving mass labor migration to the area and deeply entrenching a highly skilled, mechanically adept workforce in the region—a demographic legacy that continues to attract heavy industry today.

4.2 The Plastics Revolution: The Birth of “Plastics Valley”

Following the conclusion of WWII, Evansville became the undisputed epicenter of the American plastics revolution. In 1935, Thomas Morton Jr., owner of an Evansville metal stamping company named Hoosier Cardinal (which primarily manufactured metal ice cube trays and refrigerator shelf studs for Sears Roebuck), was introduced to a revolutionary new injection-molded process developed in Germany. Recognizing the thermodynamic limitations of metal in refrigeration, Morton sent an associate, Jack Bauer, to Germany to study the process and subsequently imported advanced Isoma plastics injection molding machines to Evansville.

This early adoption catalyzed an explosion of innovation. Hoosier Cardinal partnered with a local Evansville chemical company, Red Spot Paint and Varnish, to develop the “See-Deep” process—a method of applying complex three-dimensional paint coatings to plastic automotive medallions for Nash Motors. The overwhelming commercial success of Hoosier Cardinal led to a rapid proliferation of spin-off companies. Former employees, leveraging Evansville’s dense network of highly skilled tool-and-die makers, founded legacy firms such as Fiberfil, Kent Plastics, Windsor Plastics, and Sunbeam Plastics.

The industry expanded exponentially when General Electric (GE) Plastics established a massive plant in nearby Mount Vernon in the late 1950s to manufacture Lexan, a hardened polycarbonate plastic discovered by Daniel Fox. GE chose the Mount Vernon location for its flood safety, suitability for massive scale manufacturing, and direct access to river transport for bulk chemical precursor delivery. This unbroken chain of metallurgical and chemical innovation permanently earned the Evansville region the moniker “Plastics Valley,” mirroring California’s Silicon Valley in its concentrated industry dominance.

4.3 The Modern Industrial Ecosystem (Economic Growth Region 11)

Today, the Evansville Metropolitan Statistical Area (MSA)—categorized by the state as Economic Growth Region (EGR) 11—boasts one of the most manufacturing-intensive economies in the entire United States. According to state labor market reviews, manufacturing is the single largest industry sector in the MSA, directly employing more than 33,000 highly skilled workers.

The region demonstrates exceptionally high location quotients (LQs) in manufacturing, utilities, and mining, indicating a severe concentration of employment in heavy industry compared to the national average. The area’s infrastructure—navigable riverways, dense interstate access, and cheap industrial electricity—makes it perfect for continuous process manufacturing. This dense concentration of advanced automotive assembly, pharmaceutical scale-up, and chemical compounding, coupled with direct talent pipelines from post-secondary institutions like the University of Evansville, the University of Southern Indiana, and Ivy Tech Community College, creates a profoundly fertile environment for massive R&D tax credit generation.

Part V: Industry Case Studies and Technical R&D Analysis

The following five case studies examine the most prominent, legacy industries specific to the Evansville, Indiana region. Each study details exactly why and how the sector developed within the region, identifies specific, highly technical R&D activities common to the industry, and maps those activities directly to the statutory requirements of the federal IRC § 41 and Indiana IC 6-3.1-4 R&D tax credit legal frameworks.

5.1 Case Study 1: The Plastics and Polymer Manufacturing Industry

Regional Development and History As detailed previously, Evansville is the historical “Plastics Hub of the Nation,” an industry born out of 1930s refrigerator part manufacturing by Hoosier Cardinal. Decades of continuous innovation in polymer formulation, complex extrusion, and precision tool-and-die molding cemented the city’s dominance. In 1967, Imperial Plastics was founded in Evansville. In 1983, it was acquired by Jack Berry Sr. and renamed Berry Plastics. Through a massive string of aggressive acquisitions (including Gilbert Plastics, Mammoth Containers, and Landis Plastics), the company grew into Berry Global Group, a Fortune 500 powerhouse headquartered in Evansville, employing over 4,000 local team members across nine locations in the region.

Qualifying R&D Activities (The Technical Challenge) Consider a hypothetical Evansville-based packaging manufacturer (similar to Berry Global or Crescent Plastics) attempting to develop a new, highly sustainable, ultra-thin polyethylene flexible film for the medical industry. The film must maintain absolute, verifiable barrier properties against moisture and oxygen while utilizing a minimum of 30 percent post-consumer recycled (PCR) resin content to meet new sustainability mandates.

Federal Eligibility Assessment (IRC § 41)

• Permitted Purpose: The development of a genuinely new functional product (the ultra-thin medical film) intended specifically to improve performance and environmental sustainability, rather than a mere aesthetic change.
• Elimination of Uncertainty: The polymer engineering team is highly uncertain of the optimal chemical blend ratio of virgin resin to PCR content. Furthermore, they face thermodynamic uncertainty regarding whether the proposed extrusion temperature profiles will cause the heavily degraded recycled polymers to fracture or crystallize incorrectly during the blown film cooling process.
• Process of Experimentation: The engineers design multiple experimental resin batches. They systematically manipulate barrel temperatures, screw rotation speeds, and cooling ring air dynamics. They cast dozens of pilot rolls and subject them to rigorous physical testing, including tensile strength analysis, tear resistance checks, and microscopic oxygen transmission rate (OTR) testing to validate the barrier properties.
• Technological in Nature: The developmental work fundamentally relies on the hard sciences of materials science, polymer chemistry, thermodynamics, and chemical engineering.

Indiana Eligibility and Compliance (IC 6-3.1-4) The W-2 salaries of the polymer chemists and extrusion technicians operating exclusively out of the Evansville headquarters constitute highly eligible Indiana QREs. The massive volumes of raw resin and chemical additives consumed and rendered unsalable during the experimental pilot runs qualify as essential Supply QREs. However, given the DOR’s notoriously strict contemporaneous documentation rules, the manufacturer absolutely cannot rely on post-year financial estimates of resin waste. They must maintain explicit batch records, machine log outputs, and laboratory testing results pinpointing exact timestamps and employee hours dedicated to the experimental runs. Any highly specialized testing equipment purchased explicitly for this endeavor, such as an OTR spectrometer, would be 100 percent exempt from Indiana sales tax via the execution of Form ST-105.

5.2 Case Study 2: Automotive Assembly and Advanced Fabrication

Regional Development and History Indiana possesses an incredibly deep automotive manufacturing history, dating back to Studebaker in South Bend, heavily localized in the southern part of the state due to highway logistics advantages, proximity to primary steel mills in Lake County, and an embedded skilled mechanical workforce. In 1998, Toyota Motor Manufacturing Indiana (TMMI) commenced massive production operations in Gibson County, located directly within the Evansville MSA. Producing over 6 million vehicles since its inception, TMMI employs approximately 7,500 people directly and has catalyzed a vast, highly technical network of tier-one and tier-two industrial suppliers—such as Vuteq, which employs hundreds locally to manufacture complex sub-assemblies specifically for the Highlander, Sequoia, and Sienna models.

Qualifying R&D Activities (The Technical Challenge)

A local tier-one automotive supplier in Evansville is contracted to develop a radically improved robotic assembly cell capable of joining mixed materials (aluminum panels to high-strength steel frames) for a new electric vehicle (EV) chassis. The manufacturing process requires eliminating traditional thermal spot welding entirely in favor of advanced structural adhesives and flow-drill screw technology.

Federal Eligibility Assessment (IRC § 41)

• Permitted Purpose: Designing a fundamentally new manufacturing process intended to improve production cycle efficiency, enhance joint reliability, and achieve crucial weight reduction for the EV battery load.
• Elimination of Uncertainty: Severe technical uncertainty exists regarding the appropriate viscosity and cure time of the structural adhesive at varying ambient factory temperatures. Furthermore, engineers are uncertain whether the robotic arm paths can maintain required rapid cycle times without compromising the shear integrity of the mixed-metal joints.
• Process of Experimentation: The manufacturing engineers construct a multi-million dollar pilot assembly cell. They utilize advanced 3D kinematic simulation software to model the robotic paths virtually before physical deployment. Physical trial-and-error involves incrementally adjusting the torque parameters and rotational speeds of the flow-drill screws and performing destructive shear and peel testing on the resultant joints to gather failure data.
• Technological in Nature: The experimental process relies entirely on mechanical engineering, metallurgy, and complex robotics programming.

Indiana Eligibility and Compliance (IC 6-3.1-4) The costs paid to third-party structural engineering firms based in Indiana to analyze the destructive shear testing data using specialized software would qualify as contract research QREs (subject to the 65% statutory limitation). For the Indiana Credit calculation, the tier-one supplier’s massive capital investment in QREs would easily push them into the highly lucrative 15 percent Tier 1 standard base calculation. Crucially, the supplier must rigorously ensure that any engineering sub-contractors utilized are physically conducting their analytical work within Indiana borders; utilizing an out-of-state engineering firm in Kentucky or Ohio would instantly sever the requisite nexus for state credit inclusion, despite the expenses being perfectly eligible for the federal credit.

5.3 Case Study 3: Pharmaceutical Formulation and Commercial Scale-Up

Regional Development and History The life sciences sector is a foundational pillar of the modern Indiana economy. In the Evansville area, AstraZeneca operates an immense, state-of-the-art pharmaceutical campus in Mount Vernon. Originally developed through legacy pharmaceutical investments, the facility has become a critical global hub for the company. AstraZeneca recently announced a historic, multi-billion dollar investment in US manufacturing and R&D, specifically targeting continuous manufacturing expansion at the Mount Vernon site to support the commercialization of incredibly complex novel therapeutics.

Qualifying R&D Activities (The Technical Challenge) A biopharmaceutical chemical engineering team operating in Mount Vernon is tasked with scaling up the production of a newly approved cardiovascular active pharmaceutical ingredient (API) from small laboratory-scale quantities (bench scale, typically 5 liters) to massive commercial-scale continuous manufacturing batches (5,000 liters).

Federal Eligibility Assessment (IRC § 41)

• Permitted Purpose: Designing and dramatically improving an industrial manufacturing process to massively increase product yield and ensure long-term drug stability.
• Elimination of Uncertainty: A highly sensitive chemical reaction that works perfectly in a 5-liter glass benchtop reactor behaves vastly differently in a 5,000-liter continuous flow stainless steel system due to radically altered thermodynamics, massive mixing sheer forces, and non-linear heat transfer rates. The engineering team does not know the specific mechanical agitation speeds or cooling jacket temperature profiles required to prevent thermal product degradation at scale.
• Process of Experimentation: Process engineers conduct multiple incredibly expensive pilot-scale runs, incrementally adjusting thermodynamic inputs and flow rates. They continuously evaluate the degradation profile of the API under various simulated mechanical stress conditions and refine the synthesis route parameters to optimize the final API purity.
• Technological in Nature: The activity is deeply and exclusively rooted in the hard sciences of biochemistry, pharmacology, and chemical engineering.
• IRS Audit Context: The official IRS Pharmaceutical Audit Techniques Guide explicitly acknowledges that the “scale-up of production of bulk chemical and finished dosage forms from small research quantities to large quantities” and “production facility design” are standard, acceptable QRE-generating activities categorized as low-risk for disallowance.

Indiana Eligibility and Compliance (IC 6-3.1-4) Given the immense magnitude of pharmaceutical capital requirements, the direct expenses associated with failed pilot batches—including raw chemical precursors, highly specialized reagents, and ruined APIs—represent enormous, highly valuable Supply QREs. Due to the strict DOR guidelines regarding documentation, the pharmaceutical company must ensure their enterprise cost accounting software explicitly codes and ties these ruined supply costs exclusively to the specific experimental scale-up phase, completely severing them from standard cost of goods sold (COGS) tracking. The 10-year Indiana carryforward provision is highly beneficial here, as immense pre-commercial scale-up costs may drastically outpace the company’s current year state tax liability, allowing them to shield future income once the drug hits the market.

5.4 Case Study 4: Food Science and Infant Nutrition

Regional Development and History In 1921, visionary businessman Edward Mead Johnson moved the headquarters of Mead Johnson & Company to Evansville, Indiana, attracted by the city’s strategic Midwest location, access to cheap agricultural inputs, and superior river transport networks. Operating continuously there for over a century, the company became a global behemoth in pediatric nutrition and infant formula. The Evansville facility serves as the global headquarters for Mead Johnson’s intense Research and Development operations, responsible for historic, life-saving innovations such as being the first company in the US to introduce DHA (Docosahexaenoic acid) into infant formula in 2002, and pioneering the highly complex use of Probiotic LGG and Milk Fat Globule Membrane (MFGM) in pediatric products.

Qualifying R&D Activities (The Technical Challenge)

A food science and microbiology team in Evansville is attempting to formulate a novel, ready-to-use liquid infant formula that securely suspends a new, highly temperature-sensitive probiotic strain alongside essential omega-3 fatty acids, requiring a guaranteed shelf-life of 12 months at room temperature without refrigeration prior to opening.

Federal Eligibility Assessment (IRC § 41)

• Permitted Purpose: Developing a radically new nutritional formulation that tangibly improves infant health and revolutionizes the delivery methodology.
• Elimination of Uncertainty: Severe technical uncertainty exists regarding the long-term emulsification stability of the fatty acids. Furthermore, the team is completely uncertain whether the extreme thermal stress required for commercial pasteurization will instantly denature the proteins and kill the probiotic cultures before the product can even be packaged.
• Process of Experimentation: Food chemists scientifically test various organic emulsifiers to prevent phase separation. They run iterative, highly controlled thermal processing simulations, systematically altering pasteurization hold times and spike temperatures. Subsequently, microbiologists plate and test the bacterial survival rates and utilize centrifuges to check for micro-phase separation in the liquid emulsion.
• Technological in Nature: Grounded entirely in the rigorous biological sciences, microbiology, and food engineering.

Indiana Eligibility and Compliance (IC 6-3.1-4) The high salaries for the Evansville-based microbiologists, clinical nutritionists, and quality control bench researchers actively engaged in formulating the new product represent direct, unchallenged Indiana QREs. Furthermore, if the company utilizes outside testing facilities or academic hospital partners to conduct long-term bioavailability studies or clinical safety trials on the new formula, those specific facilities must be physically located within Indiana (e.g., in Indianapolis or Bloomington) to qualify for the state contract research credit. Because food processing R&D often involves heavy, energy-intensive pilot plant trial runs, the specific utility costs (electricity, natural gas, and water) directly consumed in operating the pilot plant during the experimental pasteurization runs can also be captured as lucrative supply QREs, provided they are rigorously metered and legally documented.

5.5 Case Study 5: Aluminum Smelting and Heavy Metal Fabrication

Regional Development and History Heavy primary metals manufacturing relies fundamentally on massive, uninterrupted power generation and vast water resources for cooling, making the Indiana side of the Ohio River valley an absolutely ideal geographic location. In 1960, industrial giant Alcoa established the Warrick Operations in Newburgh, Indiana (immediately adjacent to the Evansville city limits), which rapidly grew through continuous capital investment into the world’s largest producer of coated container sheet aluminum. The massive facility handles extreme industrial processes, including active high-voltage smelting potlines and massive rolling mills, generating an estimated $6.6 million in daily economic output for the Greater Evansville region.

Qualifying R&D Activities (The Technical Challenge) The metallurgical engineering team at a primary smelting facility is tasked with designing a radically new carbon anode configuration to be used in the extreme environment of the electrochemical smelting process. The dual goal is to significantly reduce overall electricity consumption across the potline while actively capturing a much higher percentage of hazardous fluoride emissions in a newly upgraded dry-scrubber baghouse filtration system.

Federal Eligibility Assessment (IRC § 41)

• Permitted Purpose: Improving a heavy manufacturing process to drastically enhance energy efficiency, lower operational costs, and reduce environmental pollution outputs.
• Elimination of Uncertainty: The optimal physical geometry of the new carbon anodes and their specific degradation rate inside the 950°C molten cryolite bath is entirely unknown. Additionally, the exact thermodynamic airflow dynamics required to prevent the newly designed baghouse filters from clogging prematurely with fine particulate are highly uncertain.
• Process of Experimentation: Environmental and metallurgical engineers utilize advanced computational fluid dynamics (CFD) software to virtually model the complex airflow in the scrubber. Following digital simulation, they cast physical prototype anodes of varying experimental geometries, insert them into a live test potline, and meticulously measure the resultant voltage drop and particulate capture rates, altering the physical design through multiple systematic iterations based on the sensor data.
• Technological in Nature: Depends entirely on the principles of physical chemistry, high-temperature thermodynamics, and metallurgical engineering.

Indiana Eligibility and Compliance (IC 6-3.1-4) Given the immense physical scale of aluminum smelting, prototype costs are astronomically high. The thousands of pounds of raw carbon, bauxite, and molten cryolite consumed and degraded during the experimental potline runs constitute massive, highly defensible Indiana Supply QREs. The Indiana Sales and Use Tax Exemption is hyper-critical in this scenario; custom extrusion tooling, graphite molds, and expensive digital testing sensor arrays purchased specifically for the baghouse upgrade would be completely exempt from the 7 percent state sales tax. Furthermore, if the massive smelting company has a long, historically inconsistent history of high R&D spending, they may find utilizing the Alternative Simplified Credit (ASC) equivalent—calculating 10% of the excess over 50% of their 3-year average—yields a far higher financial benefit than the standard incremental method, demanding highly strategic financial modeling at the state tax level.

Part VI: Strategic Compliance and Documentation Methodology

The juxtaposition of the broad federal framework with Indiana’s highly localized, aggressive statutory demands creates an incredibly complex compliance environment for industrial businesses operating in the Evansville region. The Indiana Department of Revenue’s absolute reliance on strict, contemporaneous evidence, as starkly evidenced by recent Letters of Findings explicitly rejecting oral testimony and post-project estimation, signifies a critical reality: qualifying the science is only half the battle; documenting the science is equally paramount.

Taxpayers in the Crescent Valley must proactively implement integrated, enterprise-level project tracking systems that capture engineering time concurrently with technical project milestones. The legal defense of these millions of dollars in credits under aggressive state audit relies entirely on an airtight paper trail connecting specific employee W-2 wages and specific material purchase orders directly to the precise elimination of technical uncertainty. This is documented through locked timesheets, digital Jira tickets, signed laboratory notebooks, or securely timestamped CAD file metadata.

Furthermore, Evansville businesses must accurately and meticulously apportion costs, ensuring that an enterprise with federal QREs distributed across multiple states mathematically isolates the Indiana-specific activities for IC 6-3.1-4 compliance. This rigorous accounting shields the local Indiana entity from devastating out-of-state disallowances during an audit.

Final Thoughts

The intersection of federal IRC Section 41 and Indiana Code 6-3.1-4 provides an incredibly powerful, albeit legally complex, fiscal lever for businesses engaged in deep technical innovation. Evansville, Indiana, with its profound historical roots spanning from post-WWII plastics manufacturing to modern, advanced automotive assembly and cutting-edge pharmaceutical scale-up, represents a quintessential landscape for maximum R&D tax credit utilization. By strictly adhering to the technical mandates of the four-part test and maintaining rigorous, contemporaneous documentation specifically designed to satisfy the hostile audit posture of the Indiana Department of Revenue, Evansville manufacturers can continually reinvest in their technological capabilities. This ensures both regional economic stability for the Crescent Valley and global competitive advantage for American manufacturing.

The information in this study is current as of the date of publication, and is provided for information purposes only. Although we do our absolute best in our attempts to avoid errors, we cannot guarantee that errors are not present in this study. Please contact a Swanson Reed member of staff, or seek independent legal advice to further understand how this information applies to your circumstances.